COVID-19, myocarditis and pericarditis
DL Fairweather, DJ Beetler, DN Di Florio… - Circulation …, 2023 - Am Heart Assoc
Viral infections are a leading cause of myocarditis and pericarditis worldwide, conditions that
frequently coexist. Myocarditis and pericarditis were some of the early comorbidities …
frequently coexist. Myocarditis and pericarditis were some of the early comorbidities …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …
Extrapulmonary manifestations of COVID-19
A Gupta, MV Madhavan, K Sehgal, N Nair… - Nature medicine, 2020 - nature.com
Although COVID-19 is most well known for causing substantial respiratory pathology, it can
also result in several extrapulmonary manifestations. These conditions include thrombotic …
also result in several extrapulmonary manifestations. These conditions include thrombotic …
Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic
Abstract The coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 that has significant implications for the …
severe acute respiratory syndrome coronavirus 2 that has significant implications for the …
Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic
The COVID-19 pandemic has significantly affected the US health care system. To preserve
resources, including personal protective equipment and hospital beds to care for COVID-19 …
resources, including personal protective equipment and hospital beds to care for COVID-19 …
Cardiovascular complications in COVID-19
Background The coronavirus disease of 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and …
respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and …
COVID-19 and the heart
A Akhmerov, E Marbán - Circulation research, 2020 - Am Heart Assoc
Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical
syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 …
syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 …
Description and proposed management of the acute COVID-19 cardiovascular syndrome
Coronavirus disease 2019 (COVID-19) is a rapidly expanding global pandemic caused by
severe acute respiratory syndrome coronavirus 2, resulting in significant morbidity and …
severe acute respiratory syndrome coronavirus 2, resulting in significant morbidity and …
Management of acute myocardial infarction during the COVID-19 pandemic: a position statement from the Society for Cardiovascular Angiography and Interventions …
E Mahmud, HL Dauerman, FGP Welt… - Journal of the American …, 2020 - jacc.org
The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has
resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19) …
resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19) …
ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes
As of March 31, 2020 (median follow-up, 13 days; interquartile range, 2–20 days), 11
patients (39.3%) had died, 1 (3.6%) was still hospitalized in an intensive care unit, and 16 …
patients (39.3%) had died, 1 (3.6%) was still hospitalized in an intensive care unit, and 16 …